Approach to Invasive Fungal Infections in the PICU with Dr. Paul Sue and Dr. Sara Dong

PedsCrit

Dr. Paul Sue is an associate professor of pediatrics at the Columbia University and Director of the Pediatric Transplant and Immunocompromised Host at the Morgan Stanley Children’s Hospital in NY. He completed his pediatric residency at Jacobi Medical Center at the Albert Einstein College of Medicine in the Bronx, and his fellowship in pediatric infectious diseases at Johns Hopkins University in Baltimore. He then moved to UT Southwestern in Dallas TX, where he served as director of Pediatric ICH ID service for the next 8 years, prior to his recent move back to NY. His research interests include the impact of invasive fungal and viral infections in the immunocompromised host, leveraging measures of functional immunity to improve infectious disease outcomes in high-risk patients, and the emergence of community acquired multidrug resistant (MDR) bacterial infections in immunocompromised children.

Sara Dong, MD is an adult and pediatric infectious disease physician at Emory University School of Medicine & Children’s Healthcare of Atlanta, where her clinical focus is transplant and immunocompromised host ID. She earned her MD from the Medical University of South Carolina. She completed her internal medicine and pediatrics (Med-Peds) residency and chief residency years at Ohio State University Wexner Medical Center and Nationwide Children’s Hospital, followed by Med-Peds ID and Medical Education fellowships at Beth Israel Deaconess Medical Center and Boston Children’s Hospital. She is the creator and host of Febrile podcast and learning platform, co-host of the ID Puscast podcast, and the program director for the ID Digital Institute.
Learning Objectives

After listening to this episode on invasive candidemia, learners should be able to discuss:

1. Risk factors associated with invasive fungal infections in critically-ill immunocompromised patients.
2. Common pathogens associated with invasive fungal infections in critically-ill immunocompromised patients.
3. Principles guiding selection of empiric antifungal agents for critically-ill patients at risk of invasive fungal infections.

References:

https://febrilepodcast.com/

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infe

Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & Zac

Support the show

How to support PedsCrit:
Please complete our Listener Feedback Survey
Please rate and review on Spotify and Apple Podcasts!
Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show.

Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at [e-mail]. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.